- Wannan Medical College, Wuhu, Anhui, P.R. China – BM (MD equivalent)
- John Curtin School of Medical Research (JCSMR), The Australian National University, Canberra, Australia – PhD in Immunology and Genetics
Dr. Lixin Rui is a faculty member in the Division of Hematology, Medical Oncology and Palliative Care within the Department of Medicine. He is a lecturer and trainer in several University of Wisconsin School of Medicine and Public Health basic science courses and graduate programs. A former UW Institute for Clinical and Translational Research (ICTR) KL2 scholar, Dr. Rui has an active lymphoma biology research program. He is a member of the American Society of Hematology and the American Association for Cancer Research.
View Dr. Lixin Rui’s Publications on NCBI My Bibliography
Dr. Rui's research focuses on lymphoma biology, with an emphasis on JAK-STAT signaling in lymphomagenesis. Deregulation of this pathway contributes to pathogenesis of Hodgkin lymphoma and Non-Hodgkin lymphoma, including aggressive diffuse large B-cell lymphoma. Dr. Rui’s research aims to identify JAK and its downstream molecular targets for therapeutic applications to these cancers. His research interests also include investigation of the F-box protein FBXO10, which he has recently characterized as a potential tumor suppressor.